Basel, Switzerland

Patrick Williamson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Patrick Williamson

Introduction

Patrick Williamson is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of spinal muscular atrophy. His work has led to the development of innovative compounds that hold promise for improving patient outcomes.

Latest Patents

Williamson holds a patent for "Substituted imidazo[1,2-α]pyrazines for treating spinal muscular atrophy." This invention provides compounds of formula (I) that are designed to address the challenges associated with this debilitating condition. His patent reflects his commitment to advancing medical science and improving the lives of those affected by spinal muscular atrophy.

Career Highlights

Throughout his career, Patrick Williamson has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has equipped him with the knowledge and skills necessary to drive innovation in drug development.

Collaborations

Williamson has collaborated with esteemed colleagues such as Emmanuel Pinard and Hasane Ratni. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Patrick Williamson's contributions to the field of pharmaceuticals, particularly through his patent for treating spinal muscular atrophy, highlight his role as an innovative inventor. His collaborations and career experiences have positioned him as a key figure in advancing medical research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…